Ignite Creation Date:
2024-05-06 @ 8:03 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06238752
Status:
COMPLETED
Last Update Posted:
2024-02-02
First Post:
2024-01-24
Brief Title:
First-line Apatinib Combined With Tislelizumab and Chemotherapy for Advanced GC
Sponsor:
Organization:
Renmin Hospital of Wuhan University